{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T23:47:29Z","timestamp":1770421649632,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s13139-025-00906-4","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T09:19:53Z","timestamp":1738574393000},"page":"125-134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["[113mIn]In-AMBA: A Novel Diagnostic Agent for SPECT Imaging of GRPR-Expressing Tumors"],"prefix":"10.1007","volume":"59","author":[{"given":"Mohammad","family":"Moazami-Ashtiani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Rajabifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samaneh","family":"Zolghadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Yousefnia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"906_CR1","unstructured":"Clancy E. ACS Report Shows Prostate Cancer on the Rise, Cervical Cancer on the Decline. Renal & Urology News. 2023; 23: NA."},{"key":"906_CR2","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1021\/acsptsci.2c00173","volume":"19","author":"CW Lindsley","year":"2022","unstructured":"Lindsley CW, M\u00fcller CE, Bongarzone S. Diagnostic and therapeutic radiopharmaceuticals. ACS Pharmacol Transl Sci. 2022;19:835\u20137.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"906_CR3","doi-asserted-by":"publisher","first-page":"481","DOI":"10.7150\/thno.4024","volume":"2","author":"M Fani","year":"2012","unstructured":"Fani M, Maecke HR, Okarvi SM. Radiolabeled peptides: valuable tools for the detection and treatment of cancer. Theranostics. 2012;2:481.","journal-title":"Theranostics"},{"key":"906_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2174\/1874471016666221207122731","volume":"16","author":"F Badipa","year":"2023","unstructured":"Badipa F, Alirezapour B, Yousefnia H. An overview of radiolabeled RGD peptides for Theranostic Applications. Curr Radiopharm. 2023;16:107\u201322.","journal-title":"Curr Radiopharm"},{"key":"906_CR5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2217\/bmm-2016-0040","volume":"10","author":"F Pu","year":"2016","unstructured":"Pu F, Xue S, Yang JJ. ProCA1. GRPR: a new imaging agent in cancer detection. Biomark Med. 2016;10:449\u201352.","journal-title":"Biomark Med"},{"key":"906_CR6","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2967\/jnumed.116.188011","volume":"58","author":"C Morgat","year":"2017","unstructured":"Morgat C, MacGrogan G, Brouste V, V\u00e9lasco V, Sevenet N, Bonnefoi H, et al. Expression of gastrin-releasing peptide receptor in breast cancer and its association with pathologic, biologic, and clinical parameters: a study of 1,432 primary tumors. J Nucl Med. 2017;58:1401\u20137.","journal-title":"J Nucl Med"},{"key":"906_CR7","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1517\/14728222.2016.1164694","volume":"20","author":"P Moreno","year":"2016","unstructured":"Moreno P, Ramos-\u00c1lvarez I, Moody TW, Jensen RT. Bombesin related peptides\/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment. Expert Opin Ther Targets. 2016;20:1055\u201373.","journal-title":"Expert Opin Ther Targets"},{"key":"906_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.biopha.2016.12.083","volume":"87","author":"C de Aguiar Ferreira","year":"2017","unstructured":"de Aguiar Ferreira C, Fuscaldi LL, Townsend DM, Rubello D, de Barros AL. Radiolabeled bombesin derivatives for preclinical oncological imaging. Biomed Pharmacother. 2017;87:58\u201372.","journal-title":"Biomed Pharmacother"},{"key":"906_CR9","doi-asserted-by":"publisher","first-page":"583309","DOI":"10.3389\/fchem.2020.583309","volume":"8","author":"X Li","year":"2020","unstructured":"Li X, Cai H, Wu X, Li L, Wu H, Tian R. New frontiers in molecular imaging using peptide-based radiopharmaceuticals for prostate cancer. Front Chem. 2020;8:583309.","journal-title":"Front Chem"},{"key":"906_CR10","first-page":"1144","volume":"47","author":"LE Lantry","year":"2006","unstructured":"Lantry LE, Cappelletti E, Maddalena ME, Fox JS, Feng W, Chen J, et al. 177Lu-AMBA: synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer. J Nucl Med. 2006;47:1144\u201352.","journal-title":"J Nucl Med"},{"key":"906_CR11","first-page":"S389","volume":"31","author":"LE Lantry","year":"2004","unstructured":"Lantry LE, Thomas R, Waser B, Maddalena M, Fox JS, Arunachalam T, et al. Preclinical evaluation of Lu-177-AMBA, a DOTA conjugate that targets GRP and NMB receptor expressing tumors: internalization, in vivo biodistribution, single dose radiotherapy in PC-3 tumor-bearing nude mice and in vitro autoradiography in animal and human tissues. Eur J Nucl Med Mol Imaging. 2004;31:S389\u201390.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"supplement 2","key":"906_CR12","first-page":"79P","volume":"48","author":"R Baum","year":"2007","unstructured":"Baum R, Prasad V, Mutloka N, Frischknecht M, Maecke H, Reubi J. Molecular imaging of bombesin receptors in various tumors by Ga-68 AMBA PET\/CT: first results. J Nucl Med. 2007;48(supplement 2):79P.","journal-title":"J Nucl Med"},{"key":"906_CR13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.nucmedbio.2020.03.005","volume":"84","author":"J Zhang-Yin","year":"2020","unstructured":"Zhang-Yin J, Provost C, Cancel-Tassin G, Rusu T, Penent M, Radulescu C, et al. A comparative study of peptide-based imaging agents [68Ga] Ga-PSMA-11, [68Ga]Ga-AMBA, [68Ga]Ga-NODAGA-RGD and [68Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models. Nucl Med Biol. 2020;84:88\u201395.","journal-title":"Nucl Med Biol"},{"key":"906_CR14","doi-asserted-by":"crossref","unstructured":"Ho CL, Liu IH, Wu YH, Chen LC, Chen CL, Lee WC et al. Molecular Imaging, Pharmacokinetics, and Dosimetry of 111In-AMBA in human prostate Tumor\u2010Bearing mice. BioMed Res Int 2011;101497.","DOI":"10.1155\/2011\/101497"},{"key":"906_CR15","unstructured":"Fox J, Maddalena ME, Wedeking P, Chen J, Wang N, Linder K et al. 2007. Comparative biodistributions of 111In, 67Ga and 177Lu-AMBA in PC-3 tumor bearing mice. J Nucl Med. 79P."},{"key":"906_CR16","unstructured":"Chen J, Feng W, Arunachalam T, Metcalfe E, Nunn A, Linder K. Preparation and in vitro binding of 67Ga-AMBA, comparison to 177Lu-AMBA. Nucl Med; 2007; 48 (supplement 2) 306P."},{"key":"906_CR17","first-page":"99","volume":"45","author":"F Bolorinovin","year":"2024","unstructured":"Bolorinovin F, Mirzaei M, Faghihi R, Joharidaha F, Sina S, Hadad K, et al. Design and construction of a 113Sn\/113mIn generator using irradiation of natural indium in a cyclotron accelerator. JONSAT. 2024;45:99\u2013106.","journal-title":"JONSAT"},{"key":"906_CR18","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1515\/ract-2024-0298","volume":"112","author":"L Akbari","year":"2024","unstructured":"Akbari L, Sina S, Zolghadri S, Moghaddasi A, Hadad K, Yousefnia H. [113mIn]In-PSMA: high potential agent for SPECT imaging of prostate cancer. Radiochim Acta. 2024;112:883\u201394.","journal-title":"Radiochim Acta"},{"key":"906_CR19","unstructured":"Chu SY. The Lund\/LBNL nuclear data search. Available at: http:\/\/nucleardata.nuclear.lu.se\/nucleardata\/toi\/index. asp.1999."},{"key":"906_CR20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0020-708X(65)90182-1","volume":"16","author":"HS Stern","year":"1965","unstructured":"Stern HS, Zolle I, McAfee JG. Preparation of technetium (Tc99m)-labeled serum albumin (human). Appl Radiat Isot. 1965;16:283\u20138.","journal-title":"Appl Radiat Isot"},{"key":"906_CR21","doi-asserted-by":"crossref","unstructured":"Rookeman VA, Sun PC, Bruno FP, Dunavant BG. Internal distribution and absorbed dose calculations for radioactive indium liver and lung scanning agents. AJR Am J Roentgenol. 1970;109:735\u201341.","DOI":"10.2214\/ajr.109.4.735"},{"key":"906_CR22","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1001\/jama.1968.03140300026008","volume":"205","author":"EJ Potchen","year":"1968","unstructured":"Potchen EJ, Adatepe M, Welch M, Archer E, Studer R. Indium in 113m for visualizing Body organs: a broad spectrum scanning Agent. JAMA. 1968;205:208\u201312.","journal-title":"JAMA"},{"key":"906_CR23","first-page":"18","volume":"10","author":"RE O\u2019Mara","year":"1969","unstructured":"O\u2019Mara RE, Subramanian G, McAfee JG, Burger CL. Comparison of 113mIn and other short-lived agents for cerebral scanning. J Nucl Med. 1969;10:18\u201327.","journal-title":"J Nucl Med"},{"key":"906_CR24","first-page":"29","volume":"45","author":"F Bolourinovin","year":"2024","unstructured":"Bolourinovin F, Mirzaei M, Faghihi R, Joharidaha F, Sina S, Hadad K, et al. Preparation, Quality control, Biodistribution of [113mIn]In-DOTATATE. JONSAT. 2024;45:29\u201335.","journal-title":"JONSAT"},{"key":"906_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.apradiso.2007.11.007","volume":"66","author":"J Chen","year":"2008","unstructured":"Chen J, Linder KE, Cagnolini A, Metcalfe E, Raju N, Tweedle MF, et al. Synthesis, stabilization and formulation of [177Lu] Lu-AMBA, a systemic radiotherapeutic agent for gastrin releasing peptide receptor positive tumors. Appl Radiat Isot. 2008;66:497\u2013505.","journal-title":"Appl Radiat Isot"},{"key":"906_CR26","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s10967-015-4290-3","volume":"307","author":"U Pandey","year":"2016","unstructured":"Pandey U, Mukherjee A, Jindal A, Gamre N, Korde A, Ram R, et al. Preparation and evaluation of a single vial AMBA kit for 68 Ga labeling with potential for imaging of GRP receptor-positive cancers. J Radioanal Nucl Chem. 2016;307:1115\u201324.","journal-title":"J Radioanal Nucl Chem"}],"container-title":["Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13139-025-00906-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13139-025-00906-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13139-025-00906-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T08:50:32Z","timestamp":1742374232000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13139-025-00906-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["906"],"URL":"https:\/\/doi.org\/10.1007\/s13139-025-00906-4","relation":{},"ISSN":["1869-3474","1869-3482"],"issn-type":[{"value":"1869-3474","type":"print"},{"value":"1869-3482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]},"assertion":[{"value":"1 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal studies were performed in accordance with the United Kingdom Biological Council\u2019s Guidelines and under supervision of NSTRI (Nuclear Science and Technology Research Institute, Tehran, Iran, the approval number: RA-0-IN-0110-16).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Mohammad Moazami-Ashtiani, Saeed Rajabifar, Samaneh Zolghadri and Hassan Yousefnia declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}